Roche Applied Science, a business area of Roche Diagnostics, and the Foundation for Innovative New Diagnostics (FIND) have signed a Letter of Intent to further explore possibilities for the development or support of projects in the area of in-vitro diagnostics (IVD) products for poverty-related diseases.
FIND and Roche Diagnostics agreed to evaluate several fields of collaboration of common interest, to evaluate possibilities for introduction of new diagnostic tools in the public health sector of high endemic countries. Among other aspects of this collaboration, FIND will be responsible for conducting studies for the technical product evaluation in relevant clinical settings in developing countries. Roche will bring in their experience in development and service in diagnostics.
Roche is the world leader in in-vitro diagnostics and through its wide range of innovative products has contributed to major medical advances in modern medicine.
As a leading public-private partnership in the area of diagnostics, FIND's main objective is to adapt the most sophisticated technologies to the needs of underprivileged people in developing countries to better fight poverty-related diseases. FIND's disease portfolio currently includes tuberculosis, sleeping sickness, and - more recently- malaria.
"Roche is glad to cooperate with FIND in this very important field of poverty-related diseases. As one of the leading healthcare companies in the world it is Roche's mission to support people with high-quality diagnostic products that fit for their specific needs," stated Dr. Manfred Baier, Head of Roche Applied Science.
"We are very pleased and look forward to collaborating with Roche Diagnostics to evaluate possibilities for facilitation the medical needs in developing countries," said FIND Chief Executive Officer, Dr. Giorgio Roscigno. "One of FIND's principal roles is to serve as a bridge between the private and public sector, and we are hopeful that IVD tools that are efficient, user-friendly and affordable can significantly increase the quality of diagnosis in these regions."
Corporate social responsibility at Roche Over and above its primary role as an innovative healthcare business, Roche also has a long heritage of wider community involvement - in humanitarian and social projects centered mainly in Least Developed Countries. Further information please find at: http://www.roche.com/...
About FIND The Foundation for Innovative New Diagnostics (FIND) is a non-profit Swiss foundation based in Geneva. Its purpose is to support and promote the health of people in developing countries by sponsoring the development and introduction of new but affordable diagnostic tools for poverty related diseases. FIND's current donors include the Bill & Melinda Gates Foundation, USAID, the European Union and the Dutch Government.
For more information: www.finddiagnostics.org.
FIND and Roche Diagnostics agreed to evaluate several fields of collaboration of common interest, to evaluate possibilities for introduction of new diagnostic tools in the public health sector of high endemic countries. Among other aspects of this collaboration, FIND will be responsible for conducting studies for the technical product evaluation in relevant clinical settings in developing countries. Roche will bring in their experience in development and service in diagnostics.
Roche is the world leader in in-vitro diagnostics and through its wide range of innovative products has contributed to major medical advances in modern medicine.
As a leading public-private partnership in the area of diagnostics, FIND's main objective is to adapt the most sophisticated technologies to the needs of underprivileged people in developing countries to better fight poverty-related diseases. FIND's disease portfolio currently includes tuberculosis, sleeping sickness, and - more recently- malaria.
"Roche is glad to cooperate with FIND in this very important field of poverty-related diseases. As one of the leading healthcare companies in the world it is Roche's mission to support people with high-quality diagnostic products that fit for their specific needs," stated Dr. Manfred Baier, Head of Roche Applied Science.
"We are very pleased and look forward to collaborating with Roche Diagnostics to evaluate possibilities for facilitation the medical needs in developing countries," said FIND Chief Executive Officer, Dr. Giorgio Roscigno. "One of FIND's principal roles is to serve as a bridge between the private and public sector, and we are hopeful that IVD tools that are efficient, user-friendly and affordable can significantly increase the quality of diagnosis in these regions."
Corporate social responsibility at Roche Over and above its primary role as an innovative healthcare business, Roche also has a long heritage of wider community involvement - in humanitarian and social projects centered mainly in Least Developed Countries. Further information please find at: http://www.roche.com/...
About FIND The Foundation for Innovative New Diagnostics (FIND) is a non-profit Swiss foundation based in Geneva. Its purpose is to support and promote the health of people in developing countries by sponsoring the development and introduction of new but affordable diagnostic tools for poverty related diseases. FIND's current donors include the Bill & Melinda Gates Foundation, USAID, the European Union and the Dutch Government.
For more information: www.finddiagnostics.org.
